Low-grade tumours ordinarily harbour relatively few genomic aberrations (often activating point mutations in oncogenes such as FGFR3, PIK3CA and RAS [8]), typically exhibit luminal expression subtypes, and can be subdivided into two groups on the basis of CNVs (GS1 and GS2) [9]. Here, PIK3CA is linked to neoplasm.